Please login to the form below
Single Pfizer/BioNTech dose induces strong immune response to COVID-19
Study finds 99% of people generated a robust immune response against COVID-19 after single vaccine dose
UK plans to launch new national health agency focused on tackling pandemics
The UK Health Security Agency will protect against future health threats
UK COVID-19 vaccination drive hit with supply delays over the coming weeks
Weekly vaccine supplies face a 'significant reduction' from 29 March
First shipments of AZ/Oxford COVID-19 vaccine sent through COVAX
First COVAX shipments of vaccine dispatched to Ghana and Cote D’Ivoire
UK introduces Rare Diseases Framework to improve the lives of people with rare diseases
bluebird bio releases a video to raise awareness – Rare Disease Day 2021 is on 28 February
EU set to contribute €1bn to COVAX
EU had already pledged €500m to the international vaccine-sharing facility
The World Bank is working towards standardising COVID-19 vaccine contracts
The World Bank is providing $12bn to help poor countries purchase and distribute vaccines, tests and treatments for COVID-19
Researchers suggest delaying second dose of Pfizer/BioNTech jab to protect more people
Canada-based researchers Skowronski and De Serres say first dose is ‘highly protective’
Richest countries are on course to purchase one billion excess COVID-19 vaccines, new analysis finds
Report from the ONE Campaign considered vaccine supply deals agreed by G20 countries and the EU
Who's calling the shots in European healthcare?
Patients versus Pharma: industry too powerful, and too cosy with EMA, says Yannis Natsis
-
The shifting healthcare landscape -
The power of pharma businesses to drive social changeThe importance of CSR programmes
-
UK hits ‘significant milestone’ as 15 million people receive their first COVID-19 vaccine doseThe NHS also announced that five additional large-scale vaccination centres will open this week
-
South Africa puts AZ/Oxford COVID-19 vaccine roll-out on hold Pre-print study results found jab offers 'minimal' protection against B.1.351 variant
-
Full impact of COVID-19 pandemic on cancer treatment unknown, according to GlobalDataWorld Cancer Day (4 February 2021) is aiming to address systemic weaknesses exacerbated by pandemic
-
UK vaccinations top nine million as concerns rise over South Africa variantSurge testing is set to take place in eight areas linked to variant
-
AZ and EU fail to solve COVID-19 vaccine delivery issues
AZ temporarily reduced Q1 deliveries to the EU last week
-
Janet Woodcock named acting commissioner of the FDAPresident Biden is set to formally nominate a commissioner soon
-
Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactionsPossible adverse events reported at a vaccination centre in the US
-
NICE looks internally for new chief executive Deputy chief exec Gillian Leng is set to take the helm
-
Paris biocluster appoints Stéphane Roques as new chiefFormer general manager for Emmanuel Macron's party to spearhead Paris' bid to attract life sciences investment
-
Picker appoints new CEOChris Graham to focus on person-centred care
-
EFPIA appoints new director generalNathalie Moll takes up the role from April
-
IFPMA appoints director generalThomas Cueni brings expertise from Interpharma and EFPIA
Latest healthcare appointments
COVID-19 Updates and Daily News
Featured jobs
-
Account Management
-
Competitive Salary Offered
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- Virtual congresses: video thrilled the cardio tsar
- FDA approves Roche’s Actemra COVID-19 trial
- Merck & Co halts development of potential COVID-19 drug MK-7110
- Virtually, the same: Is it time to rethink congress strategy?
- When Wireless Technology Meets Drug Delivery
- Effective Leadership During & After the COVID-19 Pandemic
- Live Webinar: Exploring Digital Health From a Patient Perspective
- InSite Events™ National Pharma Meeting: A Customer Story
PMHub
AMICULUM Limited
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...
Latest intelligence
- InSite Events™ National Pharma Meeting: A Customer Story
- How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
- Fear or encouragement, which is best to drive behaviour change?
- The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
- The unheard, unseen, and uncorrected effects of COVID-19
- The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...
Quick links
Infographics
